CorMedix IncCRMD
Price$7.42

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $400.1M+225.8% YoYTTM through 31 Mar 2026
Net Income $181MTTM through 31 Mar 2026
Free Cash Flow $136.1MTTM through 31 Mar 2026

Margins

Current
Gross Margin82.5%
Operating Margin48.2%
Net Margin30.3%

Returns

41.4%ROE
22.2%ROA
9.6%ROIC

Balance Sheet Health

Debt / Equity0.33x
Current Ratio2.98x
Net Debt-$30.7Mnet cash position
Cash & Equivalents$178.1M

Quality Metrics

FCF Margin34.0%
Earnings-Beat Rate75.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.